MENU
Advertisement
Show Filters
Refine by Content Type
Refine by Year
Sort By:
Choose Sites to Search:
The Endurant Stent Graft: Consistent Clinical Performance, Trial After Trial
Overview of clinical studies and registries evaluating the Endurant stent graft system.
By Frank Vermassen, MD, PhD, and Nathalie Moreels, MD
Boston Scientific's Eluvia DES Evaluated in IMPERIAL Long Lesion Substudy
June 25, 2020—Frank Vermassen, MD, presented 2-year outcomes from the IMPERIAL Long Lesion substudy during the 2020 Vascular Interventional Advances (VIVA) late-breaking clinical trial live-stream.
IMPERIAL Subanalyses Support Boston Scientific's Eluvia Stent in Calcified Lesions and CTOs
April 16, 2019—Boston Scientific Corporation announced that results from subanalyses of the IMPERIAL clinical trial for the company's Eluvia drug-eluting vascular stent system were presented by Frank Vermassen, MD, at the Charing Cross Symposium, held April 15–18 in London, United Kingdom.
Biotronik’s Passeo-18 Lux DCB Evaluated in Isolated Popliteal Lesions at 24 Months
September 14, 2023—Biotronik announced 2-year results from the BIOLUX P-III BENELUX All-Comers Registry.
Philips Launches VesselNavigator in International Markets
April 29, 2015—Royal Philips Electronics announced the launch of VesselNavigator in Europe and other markets outside of North America.
EVAR 2020: Training Future Aortic Specialists
Emerging needs and the role of simulation.
By David Pakeliani, MD; Isabelle Van Herzeele, MD, PhD; Mario L. Lachat, MD; and Frank E.G. Vermassen, MD, PhD
An Overview of the ROADSTER Trial
Evaluation of transcarotid CAS with dynamic flow reversal.
By Christopher J. Kwolek, MD, and Richard M. Ruedy
